RT @kamleshkhunti: Registered clinical trials for #COVID-19-China & USA account for 87.6% of the studies! Many unlikely to have scientific…
Registered clinical trials for #COVID-19-China & USA account for 87.6% of the studies! Many unlikely to have scientific value? https://t.co/XeZeFKT0hk https://t.co/QqFkkuuTyD
RT @NaudetFlorian: Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis | BMJ Open h…
RT @pmanickam: Clinical trials for #COVID19 Total=201 92 drugs or plasma, incl 64 in monotherapy & 28 combinations 8 products or combinatio…
RT @pmanickam: Clinical trials for #COVID19 Total=201 92 drugs or plasma, incl 64 in monotherapy & 28 combinations 8 products or combinatio…
Clinical trials for #COVID19 Total=201 92 drugs or plasma, incl 64 in monotherapy & 28 combinations 8 products or combinations=new molecular entities 193 products=wide range of prior medical uses Many trials lack features to optimise their scientific v
RT @RetractionWatch: "While accelerating morbidity and mortality from the COVID-19 pandemic has been paralleled by early and rapid clinical…
Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis | BMJ Open https://t.co/CvAibAOV4C
"While accelerating morbidity and mortality from the COVID-19 pandemic has been paralleled by early and rapid clinical investigation, many trials lack features to optimize their scientific value." https://t.co/GkEGGByTat
Characteristics of registered clinical trials assessing treatments for #COVID-19: a cross-sectional analysis https://t.co/laGKJ0NVAG
Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis | BMJ Open https://t.co/ur6KFZxaTT
Many COVID trials are poorly designed: Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis https://t.co/8vtofKAPqv via @BMJ_Open
Så lærte vi også, at vi globalt set er ret dårlige til at sætte gode kliniske studier op i en fart, når vi møder en pandemi som #Covid_19. https://t.co/QXYu3OZUVK https://t.co/GuKyscorDG
Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis https://t.co/JomxxEk3IJ
COVID 19 Data—we asked for it. We got it. But was it very good? Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis https://t.co/0gUEwcn4ju
RT @RetractionWatch: "While accelerating morbidity and mortality from the #COVID-19 pandemic has been paralleled by early and rapid clinica…
RT @RetractionWatch: "While accelerating morbidity and mortality from the #COVID-19 pandemic has been paralleled by early and rapid clinica…
RT @mehtahemal: Majority of First-Wave COVID-19 Clinical Trials Have Significant Design Shortcomings. https://t.co/csvNTEGXex https://t.…
Nice work Hemal!
RT @RetractionWatch: "While accelerating morbidity and mortality from the #COVID-19 pandemic has been paralleled by early and rapid clinica…
Majority of First-Wave COVID-19 Clinical Trials Have Significant Design Shortcomings. https://t.co/csvNTEGXex https://t.co/dajEtNu2Jn
RT @RetractionWatch: "While accelerating morbidity and mortality from the #COVID-19 pandemic has been paralleled by early and rapid clinica…
RT @RetractionWatch: "While accelerating morbidity and mortality from the #COVID-19 pandemic has been paralleled by early and rapid clinica…
"While accelerating morbidity and mortality from the #COVID-19 pandemic has been paralleled by early and rapid clinical investigation, many trials lack features to optimise their scientific value." @mehtahemal et al in @BMJ_Open. https://t.co/GkEGGByTat